132 related articles for article (PubMed ID: 7021448)
1. Multicentre study with viloxazine (Vivalan) in depressed patients.
Kabes J; Dostal T; Náhunek K; Svestka J; Molcan J; Caplová T; Hynek K; Faltus F; Holland RP
Int Pharmacopsychiatry; 1980; 15(4):228-39. PubMed ID: 7021448
[No Abstract] [Full Text] [Related]
2. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
Sebjanic V; Grombein S
Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
[TBL] [Abstract][Full Text] [Related]
3. [Clinical trials of viloxazine in depressive states].
Fontan M; Goudemand M; Pellerin-Millecamps E
Encephale; 1979; 5(3):243-9. PubMed ID: 385296
[No Abstract] [Full Text] [Related]
4. [Clinico-experimental data on the efficacy of viloxazine in depressive states].
Pirozynski T; Chiriţă V; Mungiu OC; Luchian M; Cosmovici N
Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):49-52. PubMed ID: 3393762
[No Abstract] [Full Text] [Related]
5. Comparison of Vivalan (viloxazine hydrochloride) with imipramine in the treatment of depression. A double-blind study.
Santonastaso P; Maistrello I; Battistin L
Acta Psychiatr Scand; 1979 Aug; 60(2):137-43. PubMed ID: 388987
[TBL] [Abstract][Full Text] [Related]
6. Viloxazine in the treatment of depression: psychophysical measures and clinical response.
Amin MM; Ban TA; Lehmann HE; Khan P
Psychopharmacol Bull; 1978 Jan; 14(1):33-5. PubMed ID: 625536
[No Abstract] [Full Text] [Related]
7. Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical study.
Petrie WM; Ban TA; Wilson WH; Jamieson RC; Guy W
Int Pharmacopsychiatry; 1982; 17(4):280-6. PubMed ID: 7185772
[TBL] [Abstract][Full Text] [Related]
8. A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.
Tosca P; Zerbi F; Romani A; Molini G; Cairoli S; Montagna M; Gabba A; Groppi A
Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):270-3. PubMed ID: 4008117
[TBL] [Abstract][Full Text] [Related]
9. A double-blind trial: vivalan against placebo in depressed elderly patients.
Von Knorring L
J Int Med Res; 1980; 8(1):18-21. PubMed ID: 6987113
[TBL] [Abstract][Full Text] [Related]
10. Viloxazine in the treatment of depressive neurosis: a controlled clinical study with doxepin and placebo.
McEvoy JP; Sheridan WF; Stewart WR; Ban TA; Wilson WH; Guy W; Schaffer JD
Br J Psychiatry; 1980 Nov; 137():440-3. PubMed ID: 7008890
[TBL] [Abstract][Full Text] [Related]
11. Recognition of adverse drug reactions in depressed patients treated with viloxazine (Vicilan).
Maistrello I; Grassi G; Bertolino A; Valerio P; Pistollato G; Soverini S
Adv Biochem Psychopharmacol; 1982; 32():369-73. PubMed ID: 7090902
[No Abstract] [Full Text] [Related]
12. A comparative study of viloxazine and imipramine in the treatment of depressive states.
Elwan O
J Int Med Res; 1980; 8(1):7-17. PubMed ID: 7358207
[No Abstract] [Full Text] [Related]
13. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
[TBL] [Abstract][Full Text] [Related]
14. Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical study.
Petrie WM; McEvoy JP; Wilson WH; Ban TA; Guy W
Int Pharmacopsychiatry; 1980; 15(3):193-6. PubMed ID: 7016802
[TBL] [Abstract][Full Text] [Related]
15. [A comparative study of viloxazine and imipramine (author's transl)].
Floru L; Tegeler J
Pharmakopsychiatr Neuropsychopharmakol; 1979 Jul; 12(4):313-20. PubMed ID: 386389
[No Abstract] [Full Text] [Related]
16. A sequential trial of viloxazine (Vivalan) and imipramine in moderately depressed patients.
Davies B; Joshua S; Burrows G; Poynton C
Med J Aust; 1977 Apr; 1(15):521-2. PubMed ID: 875786
[TBL] [Abstract][Full Text] [Related]
17. A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives.
Guy W; Ban TA; McEvoy JP; Petrie WM; Wilson WH; Schaffer JD
Int Pharmacopsychiatry; 1982; 17(1):36-42. PubMed ID: 7045017
[TBL] [Abstract][Full Text] [Related]
18. [Results of the clinical trial with viloxazine (Vivalan ICI). A part of the multicentre study (author's transl)].
Kabes J; Dostal T
Cesk Psychiatr; 1979 Aug; 75(4):225-31. PubMed ID: 393416
[No Abstract] [Full Text] [Related]
19. [On the position of viloxazin in the group of antidepressants (author's transl)].
Náhunek K; Svestka J; Cesková E; Misurec J
Cesk Psychiatr; 1978 Feb; 74(1):3-8. PubMed ID: 352549
[No Abstract] [Full Text] [Related]
20. Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels.
Altamura AC; Mauri MC; Guercetti G
Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):67-75. PubMed ID: 3704174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
